| __timestamp | Bio-Techne Corporation | Intra-Cellular Therapies, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 106352000 | 21226345 |
| Thursday, January 1, 2015 | 144969000 | 139626 |
| Friday, January 1, 2016 | 162364000 | 93831530 |
| Sunday, January 1, 2017 | 188462000 | 79419009 |
| Monday, January 1, 2018 | 210850000 | 368673 |
| Tuesday, January 1, 2019 | 240515000 | 477121 |
| Wednesday, January 1, 2020 | 255497000 | 1895029 |
| Friday, January 1, 2021 | 298182000 | 8034589 |
| Saturday, January 1, 2022 | 349103000 | 20443000 |
| Sunday, January 1, 2023 | 366887000 | 33745000 |
| Monday, January 1, 2024 | 389335000 |
In pursuit of knowledge
In the dynamic world of biotechnology, cost efficiency is a critical factor for success. This analysis compares the cost of revenue efficiency between two prominent players: Bio-Techne Corporation and Intra-Cellular Therapies, Inc., from 2014 to 2023. Over this period, Bio-Techne consistently demonstrated superior cost management, with its cost of revenue growing from approximately $106 million in 2014 to nearly $389 million in 2023. In contrast, Intra-Cellular Therapies showed a more volatile pattern, with costs peaking at around $94 million in 2016 before stabilizing to about $33 million in 2023. Notably, Bio-Techne's cost of revenue increased by about 266% over the decade, while Intra-Cellular Therapies experienced a more modest growth of approximately 59%. This disparity highlights Bio-Techne's robust scalability and operational efficiency, positioning it as a leader in the biotech sector.
Comparing Cost of Revenue Efficiency: Johnson & Johnson vs Bio-Techne Corporation
Cost Insights: Breaking Down AbbVie Inc. and Intra-Cellular Therapies, Inc.'s Expenses
BeiGene, Ltd. vs Intra-Cellular Therapies, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Intra-Cellular Therapies, Inc. vs Grifols, S.A.
Cost of Revenue Comparison: Intra-Cellular Therapies, Inc. vs BioCryst Pharmaceuticals, Inc.
Cost of Revenue Trends: Bio-Techne Corporation vs Walgreens Boots Alliance, Inc.
Comparing Cost of Revenue Efficiency: Bio-Techne Corporation vs Halozyme Therapeutics, Inc.
Analyzing Cost of Revenue: Bio-Techne Corporation and Alkermes plc
Analyzing Cost of Revenue: Bio-Techne Corporation and Xenon Pharmaceuticals Inc.
Bio-Techne Corporation vs Vericel Corporation: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Bio-Techne Corporation vs Wave Life Sciences Ltd.
Comparing Cost of Revenue Efficiency: Bio-Techne Corporation vs Galapagos NV